Autoliv Stock (ALV): EPS ’Crashed’ 38% — So Why We’re BUYING It (Q2 2026)

Vista Energy Stock (VIST): EBITDA Nearly DOUBLED — So Why the ’Miss’? (Q2 2026)

Vista Energy (VIST) Q2 2026 — Vista Energy (VIST) reported Q2 2026 (Jul 16): total revenue ~$1.21B (+89% YoY); adjusted EBITDA $805M (+99% YoY) at a 70% margin; production 156,061 boe/d (+32% YoY, ~87% oil), oil 135,427 bbl/d (+33%); realized oil $89.4/bbl (+44% YoY) at a $4.5/boe lifting cost. Reported EPS was $3.0 (+37% YoY, flattered by an acquisition gain), but ADJUSTED EPS of $2.38 MISSED the ~$3.15 consensus - the shortfall was below-the-line, as D,D&A jumped 53% to $271M and taxes doubled while Vista consolidated the Equinor (Bandurria Sur / Bajo del Toro) assets acquired in May. Capex $467M; free cash flow $491M ex-acquisition. Net debt $3.06B; net leverage 1.41x (1.25x pro forma), targeting ~1.0x by year-end. Guidance: ~158k boe/d for 2026 (Q4 ramping toward ~170k) and ~$3.0B adjusted EBITDA at $85 Brent (+/- ~$200M per $10/bbl). The stock is ~$64, about 21% below its $81 high. Our EV/EBITDA work (4x 2026E EBITDA, with a deliberate Argentina discount) lands fair value ~$80. Wall Street: unanimous Buy (6/0/0), ~$85 average target. Our call: BUY, 3/5. Vista Energy is an Argentine oil producer and essentially a pure-play on Vaca Muerta - one of the best shale basins outside the U.S. In Q2 2026 the headline looked like a miss: adjusted EPS of $2.38 landed well short of the ~$3.15 consensus, and yet the operational quarter was a blowout - production up 32% to 156,061 boe/d, revenue up 89%, and adjusted EBITDA up 99% to $805M at a 70% margin. The 'miss' was below the line: reported EPS was actually $3.0 (up 37%, helped by an acquisition gain), but adjusted earnings were dragged by a 53% jump in depreciation (to $271M) and a doubling of taxes as Vista consolidated the Equinor assets (Bandurria Sur and Bajo del Toro) it acquired in May - the accounting cost of scaling up, not a crack in the business. Vista realized $89.40/bbl for its oil at a $4.50/boe lifting cost (one of the lowest anywhere), exports about two-thirds of its crude for hard currency, and generated $491M of free cash flow ex-acquisition. The deal did push net debt to $3.06B and leverage to 1.41x (1.25x pro forma), with management targeting ~1.0x by year-end. 2026 guidance: ~158k boe/d (Q4 toward ~170k) and ~$3.0B adjusted EBITDA at $85 Brent. On EV/EBITDA - the right lens for a commodity producer - Vista trades at barely ~3x this year's EBITDA; at 4x, with a deliberate Argentina discount, fair value is ~$80 vs ~$64 today. Wall Street is a unanimous Buy (6/0/0) with a ~$85 target. Our call: BUY, 3/5 - a cheap, fast-growing, low-cost oil producer, priced for an Argentina risk (FX, export duties, capital controls) that may be overdone but is genuinely un-hedgeable. Not financial advice. THE CALL: BUY (3/5, A CHEAP, FAST-GROWING, LOW-COST VACA MUERTA OIL PRODUCER, PRICED FOR ARGENTINA RISK THAT MAY BE OVERDONE) — base-case value ~$80 vs ~$64 today. KEY METRICS: - Revenue ~$1.21B (+89% YoY); adjusted EBITDA $805M (+99% YoY), 70% margin - Production 156,061 boe/d (+32% YoY, ~87% oil); oil 135,427 bbl/d (+33%) - Realized oil $89.4/bbl (+44% YoY); lifting cost $4.5/boe (world-class low) - Reported EPS $3.0 (+37%, acquisition gain); ADJUSTED EPS $2.38 vs ~$3.15 est (MISS) - D,D&A +53% to $271M, taxes doubled - Capex $467M; free cash flow $491M ex-acquisition; net debt $3.06B; leverage 1.41x (1.25x pro forma) -> ~1.0x target - Equinor deal (Bandurria Sur 25.1% + Bajo del Toro 35%) consolidated from May 1, 2026 - FY2026 guide: ~158k boe/d (Q4 ~170k) and ~$3.0B adjusted EBITDA at $85 Brent (+/-$200M per $10/bbl) - Our EV/EBITDA fair value ~$80 vs ~$64; Wall Street unanimous Buy (6/0/0), ~$85 avg target What to watch: Bullish confirmation: production ramping toward ~170k boe/d in Q4, net leverage falling back toward ~1.0x on free cash flow, and Brent holding near $85 - each would support a re-rating from ~3x toward peer multiples. The thesis breaks on an oil-price sell-off (every $10/bbl of Brent is ~$200M of second-half EBITDA) or an Argentine shock - peso devaluation, harsher export duties, or capital controls. Watch two dials above all: the Brent oil price and the net-leverage line. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Autoliv Stock (ALV): EPS ’Crashed’ 38% — So Why We’re BUYING It (Q2 2026)

Autoliv (ALV) Q2 2026 — Autoliv (ALV) reported Q2 2026 (Jul 17): net sales $2,803M (+3.3% reported, +1.0% organic - 1.3pp above a global light-vehicle-production decline of 0.3%); adjusted operating margin 9.6% (+0.4pp YoY); adjusted diluted EPS $2.43 (+10% YoY), a hair below the ~$2.46 consensus (a small miss); GAAP diluted EPS $1.35 (-38% YoY) - driven almost entirely by a one-time $90M charge (of $142M total) to discontinue manufacturing in Turkey (~2,200 jobs, closure by H1 2028, ~$40M/yr savings from 2027). The stock fell ~3.8% to ~$120. Under the hood the quarter was strong: free operating cash flow more than doubled to $340M (operating cash flow $434M, +57%); Autoliv repurchased $200M of stock (1.65M shares) and raised the dividend 24% to $0.87/quarter; net debt just $1,695M, leverage a low 1.2x. China was a highlight: sales to domestic Chinese OEMs +44% organic, now 55% of China sales (vs ~40% a year ago), with new deals signed with Great Wall Motor and XPENG; India +36%. Tariffs: >80% recovered from customers, net impact only ~$7M. FY2026 guidance: ~0% organic growth (vs LVP ~-2.5%), adjusted operating margin ~10.5-11%, operating cash flow ~$1.2B. Our owner-earnings DCF (normalized base ~$700M, 9/10/11% discount) lands ~$137 (probability-weighted at a 10% base) vs ~$120 today. Wall Street: Hold consensus (16 buy / 20 hold / 1 sell), avg target ~$129. Our call: BUY, 4/5 - the world's #1 passive-safety supplier, too cheap for its margin trajectory and ~7% total shareholder yield, mispriced for a one-time charge. Autoliv is the world's largest maker of passive safety - the airbags, seatbelts and steering wheels in cars - with about $11B in annual sales. In Q2 2026 the headline looked like a miss: GAAP diluted EPS fell 38% to $1.35 and adjusted EPS of $2.43 came a hair below the ~$2.46 consensus, and the stock fell ~3.8% to ~$120. But that GAAP 'crash' is almost entirely one item - a one-time $90M charge (part of $142M) to exit manufacturing in Turkey, a restructuring that generates ~$40M/yr of savings from 2027. Strip it out and the business clearly strengthened: adjusted EPS rose 10%, the adjusted operating margin expanded to 9.6% even after a tariff drag, free operating cash flow more than doubled to $340M, the dividend was hiked 24% to $0.87/quarter, and $200M of stock was repurchased - all from a fortress balance sheet (net debt $1.7B, 1.2x leverage). The most under-covered angle is China: as buyers shift to homegrown brands, Autoliv is riding the shift - sales to domestic Chinese OEMs grew 44% and now make up 55% of its China business (up from ~40%), with new deals with Great Wall and XPENG, plus 36% growth in India. On a normalized owner-earnings DCF (~$700M base, 9/10/11% discount) fair value lands ~$137 vs ~$120 today. Wall Street is a Hold with a ~$129 target; we differ, modestly more bullish. Our call: BUY, 4/5 - a global leader mispriced for a one-time charge, paying a ~7% total shareholder yield while margins recover. Not financial advice. THE CALL: BUY (4/5, A GLOBAL #1 SAFETY SUPPLIER, TOO CHEAP FOR ITS MARGIN RECOVERY AND ~7% SHAREHOLDER YIELD) — base-case value ~$137 vs ~$120 today. KEY METRICS: - Net sales $2,803M (+3.3% reported, +1.0% organic) vs global LVP -0.3% - Adjusted operating margin 9.6% (+0.4pp YoY); adjusted operating income $270M - Adjusted diluted EPS $2.43 (+10% YoY) vs ~$2.46 est; GAAP diluted EPS $1.35 (-38%, one-time $90M Turkey charge) - Free operating cash flow $340M (more than doubled); operating cash flow $434M (+57%) - $200M buyback (1.65M shares); dividend +24% to $0.87/qtr; net debt $1,695M; leverage 1.2x - China: domestic-OEM sales +44% organic, now 55% of China sales; India +36%; tariffs net ~$7M (>80% recovered) - FY2026 guide: ~0% organic growth (LVP ~-2.5%), adj op margin ~10.5-11%, operating cash flow ~$1.2B - Our owner-earnings DCF fair value ~$137 vs ~$120; Street Hold, ~$129 avg target What to watch: The guided Q4 adjusted-operating-margin step-up toward ~11% actually landing, and Autoliv holding its China share gains (domestic-OEM sales now 55% of its China business), would confirm the thesis; a dip toward ~$110 would open a double-digit free-cash-flow yield and a stronger buy. The thesis breaks if global light-vehicle production rolls over into a genuine downturn (guidance already assumes LVP ~-2.5%), which would drag cyclical earnings down, or if intensifying China price competition erodes the recent share gains. Watch the light-vehicle-production trend and the adjusted operating margin. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

ManpowerGroup Stock (MAN): It Already DOUBLED — Is the Easy Money Gone? | Q2 2026 Earnings

ManpowerGroup (MAN) Q2 2026 — ManpowerGroup (MAN) reported Q2 2026: revenue $4.86B (+8% reported, +6% constant currency), ahead of the ~$4.72B estimate; adjusted EPS $0.99 (beat ~$0.96, +27% cc) and GAAP EPS $1.13 (vs a $1.44 loss a year ago) — though GAAP was flattered by a net +$0.14 of one-off items, chiefly the $88M sale of Jefferson Wells. Operating profit was $112M, a razor-thin 2.3% margin. The stock had already DOUBLED off its 52-week low of ~$25 to ~$52 (+106%) ahead of the print, spiked to a fresh 52-week high near $56 on the day, then faded to roughly flat. By region, Southern Europe is ~47% of revenue ($2.31B; France alone $1.18B) but earned just $75M of profit, while the Americas ($1.21B revenue, +14%) earned nearly as much ($72M, +99%) as U.S. profit nearly tripled; Northern Europe was barely breakeven ($2M OUP). Q3 guide: adjusted EPS $0.96–$1.06 (mid $1.01), with a 2-cent FX headwind and a 44% tax rate. Capital return was reset — the dividend was cut 53% in 2025 ($1.54 to $0.72 semi-annual, ~2.8% yield now) and buybacks are paused; net debt ~$0.86B with cash down to $181M. On mid-cycle EPS of ~$5.00 at a ~10.5x normalized P/E, our fair value is ~$52 — essentially the price. Wall Street: Hold (16 of 29), avg target ~$54. Our call: HOLD, 3/5 — a real cyclical recovery, but fully priced after a +106% double. ManpowerGroup is one of the world's largest staffing and workforce-solutions firms — ~$19B in annual revenue across 70+ countries, run through three brands (Manpower, Experis, Talent Solutions). It is a low-margin (~2% operating margin), deeply cyclical business heavily concentrated in France and Southern Europe. In Q2 2026 it posted a solid beat off a low bar: revenue $4.86B (+8% reported, +6% cc) and adjusted EPS $0.99 vs ~$0.96 expected (+27% cc), with GAAP EPS $1.13 versus a $1.44 loss a year ago — though the headline was flattered by a net +$0.14 from one-offs, mainly the $88M Jefferson Wells divestiture. The catch is the chart: the stock had already more than DOUBLED off its ~$25 low to ~$52 (+106%) in anticipation of a labor-market recovery, spiked to a 52-week high near $56 on the print, then faded to roughly flat — a classic sell-the-news move. Underneath, the recovery is real but uneven: the U.S. and Latin America are surging (U.S. operating profit nearly tripled; Other Americas revenue +29%), while France — the single largest market at $1.18B revenue — was flat with profit down 12%, and Northern Europe is barely breakeven. Capital return was reset in the downturn: the dividend was cut 53% in 2025 and buybacks paused, so the once-fat yield is now ~2.8%. And a structural question hangs over the whole industry: does AI and automation shrink staffing demand over time? For valuation we normalize a deep cyclical — mid-cycle EPS of ~$5.00 at a ~10.5x staffing multiple lands fair value near ~$52, essentially today's price (soft-cycle ~$40, recovery ~$66). Wall Street agrees it's fully valued: a Hold consensus (16 of 29) with an average target around ~$54, barely above the stock. Our call: HOLD, 3/5 — a genuine, improving recovery that is now fairly priced after a +106% run; the deep-value entry was in the $20s–$30s, and we'd want the low $40s again for a margin of safety. Not financial advice. THE CALL: HOLD (3/5, A REAL CYCLICAL RECOVERY — BUT FULLY PRICED AFTER A +106% DOUBLE OFF THE LOW) — base-case value ~$52 vs ~$52 today. What to watch: We'd get constructive again in the low $40s, where a pullback would restore a real margin of safety on mid-cycle earnings. What turns us more bullish: France and Northern Europe re-accelerating (Europe is the tell), and mid-cycle EPS proving out above $5. What breaks the thesis: hiring rolling back over into a cyclical relapse, or AI and automation structurally eroding staffing demand. Watch the constant-currency revenue and operating-unit-profit trends in Europe every quarter — the Americas are already working; Europe is the swing factor. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Alcoa Stock: AA Posted a RECORD Q2 2026 — So Why Is It Down 46%? (Bargain or Value Trap?)

Alcoa Corporation (AA) Q2 2026 — Alcoa (AA) reported a record Q2 2026: revenue $3.97B (+24% QoQ, +31% YoY, a company record), adjusted EBITDA $901M (+51% QoQ), and adjusted EPS $2.12 — but that missed the ~$2.25 Street estimate, and the stock fell ~3.4% to ~$45. GAAP EPS was $1.53 ($407M net income); the 'miss' was driven by $155M of net special items (a $123M Ma'aden mark-to-market loss and $45M on energy contracts). Under the hood it was a tale of two segments: the aluminum segment earned a RECORD $1,073M EBITDA on a record realized price of $4,752/t (+51% YoY), while the alumina segment LOST $96M with its $334/t price below a $368/t cost. Free cash flow was $422M; net debt just $873M against $1.4B cash; dividend $0.10/qtr. Alcoa also agreed to buy South32's bauxite/alumina/aluminum assets ('AliGroup') for ~$4.1B upfront plus up to $750M, and cut 2026 alumina production guidance (Pinjarra/cyclone) while holding aluminum. Our EV/EBITDA scenario work lands ~$46 on mid-cycle EBITDA (~$2.4B x 5.5x, less net debt, / 264M shares) — essentially on top of the ~$45 price. Wall Street: Buy (23 of 42), avg target ~$68.50. Our call: HOLD, 3/5 — a well-run cyclical at fair mid-cycle value, at what looks like the top of the aluminum cycle. Alcoa is one of the world's largest pure-play upstream aluminum producers — it mines bauxite, refines it into alumina, and smelts alumina into aluminum, so its profits ride two volatile commodity prices. In Q2 2026 it delivered a record quarter: revenue $3.97B (+24% QoQ), adjusted EBITDA $901M (+51% QoQ), and a record realized aluminum price of $4,752/t that drove a record $1,073M aluminum-segment EBITDA. And yet the stock sits near a 52-week low, down ~46% from its $84 high, and fell ~3.4% on the print because adjusted EPS of $2.12 missed the ~$2.25 consensus — a 'miss' created almost entirely by $155M of non-cash special items (a $123M Ma'aden mark-to-market loss and $45M on energy hedges). The tension is a commodity cyclical at what looks like a price peak: aluminum is minting money while the alumina segment loses $96M (its $334/t price is below its $368/t cost), and Alcoa is spending ~$4.1B to buy South32's bauxite/alumina/aluminum assets — doubling down on the very segment that's underwater. The balance sheet is clean (net debt $873M, $1.4B cash, $422M quarterly FCF), which buys staying power. For valuation we normalize: mid-cycle adjusted EBITDA of ~$2.4B on an EV/EBITDA scenario grid lands near $46 a share — essentially today's ~$45 price — with a wide band ($42-$51 mid-cycle, $57-$69 elevated) depending entirely on where aluminum goes. Wall Street is bullish (a Buy consensus, 23 of 42 analysts, ~$68.50 target, ~51% upside), but that target essentially requires peak aluminum prices to hold plus a premium multiple. Our call: HOLD, 3/5 — a genuinely well-run producer, fairly valued at mid-cycle after a 46% fall; we'd wait for the high $30s, near a cyclical low, for a real margin of safety. Not financial advice. THE CALL: HOLD (3/5, A WELL-RUN ALUMINUM CYCLICAL — FAIRLY VALUED AT MID-CYCLE, AT WHAT LOOKS LIKE THE TOP OF THE PRICE CYCLE) — base-case value ~$46 vs ~$45 today. What to watch: The alumina segment climbing back above breakeven and the ~$4.1B South32 (AliGroup) acquisition closing on sensible terms would turn us more constructive; conversely, a pullback into the high $30s — near a genuine cyclical low — would open a real margin of safety and move us to a buy. The thesis breaks if the record ~$4,752/t realized aluminum price mean-reverts sharply, pulling earnings and the stock down together, or if the debt-funded South32 deal levers up the balance sheet at the top of the cycle. Watch the realized aluminum price above all else. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

ISRG Stock: Intuitive Surgical BEAT Q2 2026 — So Why Did It Crash 12%? (Cheap at Last, or Value Trap?)

Intuitive Surgical (ISRG) Q2 2026 — Intuitive Surgical (ISRG) reported a clean Q2 2026 beat: revenue $2.89B (+19% YoY), non-GAAP EPS $2.80 (beat $2.48, +28%), GAAP EPS $2.29; worldwide procedures +16% (da Vinci +15%, Ion +36%); 468 da Vinci systems placed (246 were da Vinci 5) vs 395 a year ago; installed base 11,710 (+12%). Instruments & accessories $1.73B (+18%, ~60% of revenue); non-GAAP gross margin 70.0%; operating margin >40%; $8.63B cash and zero debt; $0.38B buyback. Yet the stock FELL ~12.6% to a fresh 52-week low near $352 — down ~42% from its $604 high — because FY26 da Vinci procedure-growth guidance of 13.5-15.5% marked a clear step down from the high-teens, alongside softer hospital surgery volumes and a da Vinci Class II component recall. Our owner-earnings DCF lands ~$343, essentially on top of the ~$352 price. Wall Street: Buy (39 of 56), avg target ~$525. Our call: HOLD, 3/5 — a premier compounder now at roughly fair value; not a bargain yet. Intuitive Surgical is the pioneer and monopoly of robotic-assisted surgery — the da Vinci system, the Ion lung-biopsy robot, and a razor-and-blade model where over 76% of revenue recurs. In Q2 2026 it delivered a clean beat: revenue $2.89B (+19%), non-GAAP EPS $2.80 (vs $2.48), worldwide procedures +16%, non-GAAP gross margin 70%, and 468 da Vinci placements (246 da Vinci 5), lifting the installed base 12% to 11,710. And yet the stock fell ~12.6% to a fresh 52-week low near $352 — down ~42% from its $604 high. The reason isn't the quarter; it's the guide: FY26 da Vinci procedure growth of 13.5-15.5% (management points to the midpoint) is a step down from the high-teens pace of recent years, compounded by softer hospital volumes and a Class II recall. For a stock still near 33x forward earnings, decelerating procedure growth is the number that matters most. Our owner-earnings DCF (base ~$3.2B/yr, +$8.6B net cash) spans $246-$463 across 8-10% discount rates and 10-14% growth, with a probability-weighted value near $343 — roughly on top of today's ~$352. Wall Street rates it a Buy with a ~$525 target (nearly 50% upside), but even our bullish path only reaches the mid-$400s, and on the Street's own EPS estimates the math lands near our $343. Our call: HOLD, 3/5 — a wide-moat monopoly that has finally de-rated to fair value, but is not yet a bargain. Own the quality; look to add below $300; watch the quarterly procedure line above all else. Not financial advice. THE CALL: HOLD (3/5, A PREMIER SURGICAL-ROBOTICS MONOPOLY — NOW ROUGHLY FAIR, WAIT FOR A BETTER PRICE) — base-case value ~$343 vs ~$352 today. What to watch: da Vinci procedure growth stabilizing and re-accelerating back toward the high-teens (da Vinci 5 lifting procedures per system), which would justify the premium multiple — or, conversely, a pullback below ~$300 that opens a genuine margin of safety and turns us to a buy; the thesis breaks if procedure growth slides below 12% or tariff/competition pressures compress margins Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.